MicroRNAs in rheumatoid arthritis.
The role of genetic and epigenetic factors in the development of rheumatic diseases has been an interesting field of research over the past decades all around the world. Research on the role of microRNAs (miRNAs) in rheumatoid arthritis (RA) has been active and ongoing, and investigations have attempted to use miRNAs as biomarkers in disease diagnosis, prognosis, and treatment. This review focuses on experimental researches in the field of miRNAs and RA to present the data available up to this date and includes researches searched by keywords "microRNA" and "rheumatoid arthritis" in PubMed from 2008 to January 2015. All references were also searched for related papers. miRNAs are shown to act as proinflammatory or anti-inflammatory agents in diverse cell types, and their role seems to be regulatory in most instances. Researchers have evaluated miRNAs in patients compared to controls or have investigated their role by overexpressing or silencing them. Multiple targets have been identified in vivo, in vitro, or in silico, and the researches still continue to show their efficacy in clinical settings.
Immunology Department, School of Medicine, Tehran University of Medical Sciences, Poursina St, Ghods St, Enghelab Ave, Tehran, 1417613151, Iran.
Eisa
E
Salehi
Rahil
R
Eftekhari
Mona
M
Oraei
Alvand
A
Gharib
Katayoon
K
Bidad
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000235:genetics* / Q000378:metabolism*; D001327:Autoimmune Diseases / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D007107:Immune System; D007249:Inflammation; D035683:MicroRNAs / Q000378:metabolism*; D005810:Multigene Family; D011379:Prognosis; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D035683:MicroRNAs